GlobalDeal

Dicerna Pharmaceuticals, Inc.

Biotechnology · Cambridge, United States

dicerna.com

About Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of innovative therapies for the treatment of rare diseases and other serious conditions. The company specializes in RNA interference (RNAi) technology, which allows for the targeted silencing of genes responsible for disease. Dicerna's proprietary platform enables the design of RNAi-based therapeutics that can effectively target and inhibit the expression of specific genes, offering potential treatments for a range of genetic disorders and cancers. The company collaborates with various partners to advance its pipeline of product candidates, which includes therapies for conditions such as alpha-1 antitrypsin deficiency, chronic hepatitis B infection, and other liver-related diseases. Dicerna is committed to improving patient outcomes through its innovative approach to drug development and its focus on addressing unmet medical needs.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Gene Therapy, RNA Interference, Rare Diseases, Oncology
Location
Cambridge, United States
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Dicerna Pharmaceuticals, Inc. in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →